Evidence map›Paper›PMID 34588623›Full record

ArticleMolecular psychiatry2021

Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults.

Elena Rodriguez-Vieitez, Victor Montal, Jorge Sepulcre, Cristina Lois, Bernard Hanseeuw, Eduard Vilaplana, Aaron P Schultz, Michael J Properzi, Matthew R Scott, Rebecca Amariglio and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Prognostic value of plasma %p-tau217 in cognitively unimpaired older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 4 countries.

Elena Rodriguez-Vieitez *Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6639-8141
Victor Montal *Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5714-9282
Jorge SepulcreMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4199-2304
Cristina LoisMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Bernard HanseeuwMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Eduard VilaplanaSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Aaron P SchultzMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Michael J ProperziMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Matthew R ScottMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Rebecca AmariglioMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Kathryn V PappMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Gad A MarshallMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Juan ForteaSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Keith A JohnsonMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Reisa A SperlingMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Patrizia VanniniMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA. patrizia@bwh.harvard.edu.ORCID http://orcid.org/0000-0002-9425-1059
Harvard University · USBrigham and Women's Hospital · USUniversitat Autònoma de Barcelona · ES

Funding

Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)P01AG036694 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI REISA A. SPERLING · 2010 to 2026
$50.2M
Decoding neural systems underlying anosognosia for memory loss in aging and Alzheimer's diseaseR01AG061083 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI VANNINI, PATRIZIA · 2019 to 2023
$4.3M
Novel diffusion-weighted MRI assessment of cortical microstructural changes and their relationship to amyloid, tau and cognition in aging and Alzheimer's disease.R21AG064348 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI VANNINI, PATRIZIA · 2019 to 2020
$492k
NIA NIH HHS P01 AG036694NIA NIH HHS R01 AG061083NIA NIH HHS R21 AG064348
6 · The paper itself

Abstract

Noninvasive biomarkers of early neuronal injury may help identify cognitively normal individuals at risk of developing Alzheimer's disease (AD). A recent diffusion-weighted imaging (DWI) method allows assessing cortical microstructure via cortical mean diffusivity (cMD), suggested to be more sensitive than macrostructural neurodegeneration. Here, we aimed to investigate the association of cMD with amyloid-β and tau pathology in older adults, and whether cMD predicts longitudinal cognitive decline, neurodegeneration and clinical progression. The study sample comprised n = 196 cognitively normal older adults (mean[SD] 72.5 [9.4] years; 114 women [58.2%]) from the Harvard Aging Brain Study. At baseline, all participants underwent structural MRI, DWI,

Indexed as

Alzheimer DiseaseCognitive DysfunctionAgedAmyloid beta-PeptidesFemaleHumansMagnetic Resonance ImagingPositron-Emission TomographyProspective Studiestau ProteinsAmyloid beta-Peptidestau Proteins

Identifiers

PMID34588623
PMCPMC8873001
OpenAlexW3204170202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.